Back to
RA CAPITAL MANAGEMENT, L.P.
SAGEShowing 0 of 2 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in SAGE THERAPEUTICS INC
No. RA Capital Management exited its SAGE (Sage Therapeutics) position in Q2 2019. Its Q1 2019 13F listed 384,001 shares worth $61.1M. RA Capital Management first reported SAGE in Q1 2019 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of SAGE: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors